Clerkin Kevin J, Sayer Gabriel, DeFilippis Ersilia M, Colombo Paolo C, Fried Justin, Yuzefpolskaya Melana, Bae David, Oh Kyung Taek, Raikhelkar Jayant, Lotan Dor, Majure David, Naka Yoshifumi, Latif Farhana, Takeda Koji, Kumaraiah Deepa, Uriel Nir
Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
J Heart Lung Transplant. 2025 Jul 18. doi: 10.1016/j.healun.2025.07.006.
Heart transplantation (HT) is governed by the Organ Procurement and Transplantation Network, which commissions 56 organ procurement organizations (OPO) to perform allocation. Each allocation follows a match list of eligible donors ranked by urgency. We sought to describe the prevalence of OOS HT, characterize donor and recipient characteristics, and assess if the centers and recipients of OOS donors differ from non-OOS donors.
Using the Scientific Registry of Transplant Recipients all adult (≥18 years), single organ HT recipients between 1/18/2018-1/1/2024 were identified. We performed network analysis and compared in sequence vs OOS donors with multivariable logistic regression.
Among 18,394 HT, 880 (4.8%) were involved an OOS allocation for any reason (52% were OPO initiated). Four transplant centers received one-quarter (4.3%-8.5% each) of hearts allocated OOS. Six OPOs accounted for 27% of OOS allocations (4.0%-6.6% each). Graft survival was similar at 1-year between groups (90.6% vs 90.9%, p=0.79). Recipient characteristics most associated with OOS heart allocation included blood type O, UNOS Status 4 or 6, and the absence of surgical mechanical circulatory support (MCS). The most common reason for OOS allocation was expedited heart placement and the frequency was stable over time.
OOS heart allocation occurs in 4.8% HT. Nearly all centers and OPOs participated in OOS allocation, but certain were more prevalent. Recipients of OOS hearts more commonly had a lower priority status (Status 4 or 6), blood type O, and did not have surgical MCS. Further study is needed to ensure a balance between utility and equity.
心脏移植(HT)受器官获取与移植网络管理,该网络委托56个器官获取组织(OPO)进行分配。每次分配都遵循一份按紧急程度排序的合格捐赠者匹配名单。我们试图描述非原位心脏移植(OOS HT)的发生率,描述捐赠者和接受者的特征,并评估OOS捐赠者的中心和接受者与非OOS捐赠者是否不同。
利用移植受者科学注册系统,确定了2018年1月18日至2024年1月1日期间所有成年(≥18岁)单器官HT受者。我们进行了网络分析,并通过多变量逻辑回归对原位与OOS捐赠者进行了比较。
在18394例HT中,880例(4.8%)因任何原因涉及OOS分配(52%由OPO发起)。四个移植中心接收了四分之一(每个中心4.3%-8.5%)的OOS分配心脏。六个OPO占OOS分配的27%(每个OPO 4.0%-6.6%)。两组之间1年时的移植物存活率相似(90.6%对90.9%,p=0.79)。与OOS心脏分配最相关的接受者特征包括O型血、UNOS状态4或6以及无手术机械循环支持(MCS)。OOS分配的最常见原因是加快心脏安置,且随着时间推移频率稳定。
OOS心脏分配发生在4.8%的HT中。几乎所有中心和OPO都参与了OOS分配,但某些中心和OPO更为普遍。OOS心脏的接受者更常见的是优先级较低的状态(状态4或6)、O型血且没有手术MCS。需要进一步研究以确保效用和公平之间的平衡。